Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TrueBlue (TBI) Shares Issued (2017 - 2025)

TrueBlue (TBI) has disclosed Shares Issued for 17 consecutive years, with $91000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued fell 47.7% to $91000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $454000.0, a 38.48% decrease, with the full-year FY2025 number at $454000.0, down 38.48% from a year prior.
  • Shares Issued was $91000.0 for Q4 2025 at TrueBlue, down from $107000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $381000.0 in Q4 2021 to a low of $70000.0 in Q1 2025.
  • A 5-year average of $208150.0 and a median of $198500.0 in 2022 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: skyrocketed 102.66% in 2021, then crashed 68.18% in 2025.
  • TrueBlue's Shares Issued stood at $381000.0 in 2021, then plummeted by 47.51% to $200000.0 in 2022, then dropped by 24.0% to $152000.0 in 2023, then rose by 14.47% to $174000.0 in 2024, then plummeted by 47.7% to $91000.0 in 2025.
  • Per Business Quant, the three most recent readings for TBI's Shares Issued are $91000.0 (Q4 2025), $107000.0 (Q3 2025), and $186000.0 (Q2 2025).